Dr. Ronald Eugene Devine, MD

Dr. Devine practices at Atlanta I.D. Group in Atlanta, Georgia.

Dr. Devine's NPI, 1174637532, was assigned on August 19, 2006. Dr. Devine graduated from Indiana University School Of Medicine in 1997. Dr. Devine's Georgia license number on file is 51311.

Dr. Devine's primary practice is Atlanta I.D. Group, at 275 Collier NW Rd, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 351-8873.

Dr. Devine's primary practice is Atlanta I.D. Group in Atlanta, Georgia. Dr. Devine is also affiliated with Piedmont Atlanta. The medical group on file is Atlanta ID Group, P.C. Dmand AI also links Dr. Devine to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devine practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Devine's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Devine is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Devine's licenses on file in 3 states: Georgia, Kentucky and Ohio.

Dmand AI lists acute sinusitis, acute skin infection, endocarditis, immune deficiency disease, joint or bone infection and UTI among the conditions Dr. Devine treats.

CMS data shows 569 Medicare services from Dr. Devine across 7 procedure codes in 2024, for 162 Medicare patients. Medicare paid $46,545 for them.

CMS counts 162 Medicare patients who saw Dr. Devine in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devine's median patient age at 62, with 42% women.

In 2024, Dr. Devine wrote 288 Medicare Part D claims for 81 patients. 94% of them were for generic drugs. CMS names the drug for 166 of them, across 8 drugs with 11 or more claims each, at $32,584 in total drug cost. In 2023, CMS named 236 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Devine for performance year 2024, reported through an alternative payment model (APM). Dr. Devine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devine as offering telehealth.

CMS Open Payments shows 214 general payments to Dr. Devine from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Paratek Pharmaceuticals, Inc. paid the most, $1,872.

Dmand AI lists 1 award for Dr. Devine, most recently CMS Stage 1 EHR in 2013.

Dr. Devine graduated from Indiana University School Of Medicine in 1997. Dr. Devine is a member of American Board of Wound Management, American College of Clinical Wound Specialists, American College of Hyperbaric Medicine, ACP, Infectious Diseases Society of America and Undersea and Hyperbaric Medical Society.

Dr. Devine is in network with 15 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.